O'Shaughnessy Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,142	Closed	-$200K	–	2117
2024 Q2	$200K	Sell	3,142 -15	-0.5%	-$974	﹤0.01%	1542
2024 Q1	$218K	Buy	+3,157	New	+$191K	﹤0.01%	1471
2020 Q3	–	Sell	-3,297	Closed	-$107K	–	1862
2020 Q2	$107K	Sell	3,297 -9,528	-74%	-$342K	﹤0.01%	823
2020 Q1	$525K	Sell	12,825 -4,471	-26%	-$238K	0.02%	289
2019 Q4	$1.06M	Sell	17,296 -2,689	-13%	-$178K	0.02%	263
2019 Q3	$1.46M	Buy	19,985 +5,157	+35%	+$386K	0.03%	216
2019 Q2	$1.22M	Buy	+14,828	New	+$1.05M	0.03%	239

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

O'Shaughnessy Asset Management's ANIP Position: Q3 2024 in Review

O'Shaughnessy Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q3 2024, closing a stake of 3,142 shares — an estimated $200K sold.

O'Shaughnessy Asset Management first reported a position in ANIP in Q2 2019 and held it in 7 quarters. The position peaked at $1.46M in Q3 2019. 208 funds tracked by Wall St. Rank hold ANIP as of Q3 2024.

O'Shaughnessy Asset Management reported no remaining ANI Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
O'Shaughnessy Asset Management sold 3,142 ANI Pharmaceuticals shares in Q3 2024, an estimated $200K.
O'Shaughnessy Asset Management first reported a position in ANI Pharmaceuticals in Q2 2019 and held it in 7 quarters.
O'Shaughnessy Asset Management's ANI Pharmaceuticals position peaked at $1.46M in Q3 2019.
208 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2024.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.